Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Vulvar Neoplasms 1Vaginal Neoplasms 1Precancerous Conditions 1Papillomavirus Infections 1Multiple Myeloma 1Leukemia, Plasma Cell 1Esophageal Neoplasms 1Barrett Esophagus 1Atypical Squamous Cells of the Cervix 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 109Radiotherapy 100Fluorouracil 90Paclitaxel 75Oxaliplatin 63Docetaxel 56Carboplatin 55Irinotecan 41Esophagectomy 41Leucovorin 40Capecitabine 39Radiation 36Surgical Procedures, Operative 35Drug Therapy 31Neoadjuvant Therapy 25Chemoradiotherapy 18Cetuximab 18S 1 (combination) 17pembrolizumab 16camrelizumab 16Nivolumab 15Magnetic Resonance Spectroscopy 15Bevacizumab 15Blood Specimen Collection 14Surveys and Questionnaires 12Radiotherapy, Intensity-Modulated 12Immunotherapy 11Epirubicin 11Biopsy 11Trastuzumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Esophageal Neoplasms × High-Throughput Screening Assays × Clear all
NCT00987857 2017-08-22

Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus

Gloucestershire Hospitals NHS Foundation Trust

Phase NA Unknown
3,400 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡